World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies in the World as of Jul. 01, 2025

Rank Company Market Cap (USD) Country Sector Industry
361 SinoMab BioScience Ltd $313.0 M Hong Kong HK Healthcare HK Biotechnology
362 Olema Pharmaceuticals, Inc. $312.7 M United States US Healthcare US Biotechnology
363 Rocket Pharmaceuticals, Inc. $312.4 M United States US Healthcare US Biotechnology
364 Nektar Therapeutics $307.2 M United States US Healthcare US Biotechnology
365 Corvus Pharmaceuticals, Inc. $304.6 M United States US Healthcare US Biotechnology
366 Taiwan Liposome Company, Ltd. $302.9 M

(Sept. 1, 2021)

Taiwan Taiwanese Healthcare Taiwanese Biotechnology
367 Abeona Therapeutics Inc. $301.3 M United States US Healthcare US Biotechnology
368 Oyster Point Pharma, Inc. $299.9 M

(Dec. 1, 2022)

United States US Healthcare US Biotechnology
369 Healios K.K. $299.3 M Japan Japanese Healthcare Japanese Biotechnology
370 OBI Pharma, Inc. $298.6 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
371 DBV Technologies SA $298.4 M France French Healthcare French Biotechnology
372 Cerus Corporation $294.4 M United States US Healthcare US Biotechnology
373 Vanda Pharmaceuticals Inc. $292.9 M United States US Healthcare US Biotechnology
374 CHO Pharma, Inc. $292.3 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
375 Foghorn Therapeutics Inc. $286.0 M United States US Healthcare US Biotechnology
376 Cerecor Inc. $285.0 M

(June 1, 2022)

United States US Healthcare US Biotechnology
377 ADC Therapeutics SA $282.8 M Switzerland Swiss Healthcare Swiss Biotechnology
378 Gossamer Bio, Inc. $281.9 M United States US Healthcare US Biotechnology
379 Ocugen, Inc. $279.5 M United States US Healthcare US Biotechnology
380 Frontage Holdings Corp $278.4 M United States US Healthcare US Biotechnology
381 Mycenax Biotech, Inc. $270.7 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
382 Immutep Limited $266.4 M

(July 1, 2024)

Australia Australian Healthcare Australian Biotechnology
383 Imugene Limited $264.1 M

(July 1, 2024)

Australia Australian Healthcare Australian Biotechnology
384 Verastem, Inc. $263.8 M United States US Healthcare US Biotechnology
385 Mabpharm Ltd $262.7 M China Chinese Healthcare Chinese Biotechnology
386 Allogene Therapeutics, Inc. $260.3 M United States US Healthcare US Biotechnology
387 Inozyme Pharma, Inc. $258.2 M United States US Healthcare US Biotechnology
388 Aldeyra Therapeutics, Inc. $257.6 M United States US Healthcare US Biotechnology
389 Chiasma, Inc. $253.0 M

(July 1, 2021)

United States US Healthcare US Biotechnology
390 Xspray Pharma AB $252.9 M

(July 1, 2024)

Sweden Swedish Healthcare Swedish Biotechnology

Top Biotechnology Companies in the World as of Jul. 01, 2025

361. SinoMab BioScience Ltd

Company Profile: SinoMab BioScience Ltd
Market Cap (USD): $313.0 M
Country: Hong Kong
Sector: HK Healthcare
Industry: HK Biotechnology

362. Olema Pharmaceuticals, Inc.

Company Profile: Olema Pharmaceuticals, Inc.
Market Cap (USD): $312.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

363. Rocket Pharmaceuticals, Inc.

Company Profile: Rocket Pharmaceuticals, Inc.
Market Cap (USD): $312.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

364. Nektar Therapeutics

Company Profile: Nektar Therapeutics
Market Cap (USD): $307.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

365. Corvus Pharmaceuticals, Inc.

Company Profile: Corvus Pharmaceuticals, Inc.
Market Cap (USD): $304.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

366. Taiwan Liposome Company, Ltd.

Company Profile: Taiwan Liposome Company, Ltd.
Market Cap (USD): $302.9 M (Sept. 1, 2021)
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

367. Abeona Therapeutics Inc.

Company Profile: Abeona Therapeutics Inc.
Market Cap (USD): $301.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

368. Oyster Point Pharma, Inc.

Company Profile: Oyster Point Pharma, Inc.
Market Cap (USD): $299.9 M (Dec. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

369. Healios K.K.

Company Profile: Healios K.K.
Market Cap (USD): $299.3 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Biotechnology

370. OBI Pharma, Inc.

Company Profile: OBI Pharma, Inc.
Market Cap (USD): $298.6 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

371. DBV Technologies SA

Company Profile: DBV Technologies SA
Market Cap (USD): $298.4 M
Country: France
Sector: French Healthcare
Industry: French Biotechnology

372. Cerus Corporation

Company Profile: Cerus Corporation
Market Cap (USD): $294.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

373. Vanda Pharmaceuticals Inc.

Company Profile: Vanda Pharmaceuticals Inc.
Market Cap (USD): $292.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

374. CHO Pharma, Inc.

Company Profile: CHO Pharma, Inc.
Market Cap (USD): $292.3 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

375. Foghorn Therapeutics Inc.

Company Profile: Foghorn Therapeutics Inc.
Market Cap (USD): $286.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

376. Cerecor Inc.

Company Profile: Cerecor Inc.
Market Cap (USD): $285.0 M (June 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

377. ADC Therapeutics SA

Company Profile: ADC Therapeutics SA
Market Cap (USD): $282.8 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

378. Gossamer Bio, Inc.

Company Profile: Gossamer Bio, Inc.
Market Cap (USD): $281.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

379. Ocugen, Inc.

Company Profile: Ocugen, Inc.
Market Cap (USD): $279.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

380. Frontage Holdings Corp

Company Profile: Frontage Holdings Corp
Market Cap (USD): $278.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

381. Mycenax Biotech, Inc.

Company Profile: Mycenax Biotech, Inc.
Market Cap (USD): $270.7 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

382. Immutep Limited

Company Profile: Immutep Limited
Market Cap (USD): $266.4 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

383. Imugene Limited

Company Profile: Imugene Limited
Market Cap (USD): $264.1 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

384. Verastem, Inc.

Company Profile: Verastem, Inc.
Market Cap (USD): $263.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

385. Mabpharm Ltd

Company Profile: Mabpharm Ltd
Market Cap (USD): $262.7 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

386. Allogene Therapeutics, Inc.

Company Profile: Allogene Therapeutics, Inc.
Market Cap (USD): $260.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

387. Inozyme Pharma, Inc.

Company Profile: Inozyme Pharma, Inc.
Market Cap (USD): $258.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

388. Aldeyra Therapeutics, Inc.

Company Profile: Aldeyra Therapeutics, Inc.
Market Cap (USD): $257.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

389. Chiasma, Inc.

Company Profile: Chiasma, Inc.
Market Cap (USD): $253.0 M (July 1, 2021)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

390. Xspray Pharma AB

Company Profile: Xspray Pharma AB
Market Cap (USD): $252.9 M (July 1, 2024)
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Biotechnology

Stay in touch